Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1950 1
1951 3
1952 1
1953 2
1954 4
1955 2
1956 4
1957 3
1958 2
1959 2
1960 1
1962 1
1964 1
1967 1
1968 1
1978 1
1979 3
1980 6
1981 8
1982 3
1983 8
1984 5
1985 4
1986 11
1987 5
1988 2
1989 1
1990 8
1991 4
1992 8
1993 5
1994 13
1995 5
1996 9
1997 10
1998 11
1999 10
2000 13
2001 3
2002 12
2003 12
2004 18
2005 14
2006 17
2007 13
2008 12
2009 18
2010 20
2011 23
2012 19
2013 18
2014 26
2015 21
2016 23
2017 16
2018 14
2019 15
2020 14
2021 9
2022 12
2023 8
2024 10
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Results by year

Filters applied: . Clear all
Page 1
Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG; PROGRESS Group. Steyerberg EW, et al. PLoS Med. 2013;10(2):e1001381. doi: 10.1371/journal.pmed.1001381. Epub 2013 Feb 5. PLoS Med. 2013. PMID: 23393430 Free PMC article. Review.
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.
Riley RD, Hayden JA, Steyerberg EW, Moons KG, Abrams K, Kyzas PA, Malats N, Briggs A, Schroter S, Altman DG, Hemingway H; PROGRESS Group. Riley RD, et al. PLoS Med. 2013;10(2):e1001380. doi: 10.1371/journal.pmed.1001380. Epub 2013 Feb 5. PLoS Med. 2013. PMID: 23393429 Free PMC article. Review.
Neuropixels 2.0: A miniaturized high-density probe for stable, long-term brain recordings.
Steinmetz NA, Aydin C, Lebedeva A, Okun M, Pachitariu M, Bauza M, Beau M, Bhagat J, Böhm C, Broux M, Chen S, Colonell J, Gardner RJ, Karsh B, Kloosterman F, Kostadinov D, Mora-Lopez C, O'Callaghan J, Park J, Putzeys J, Sauerbrei B, van Daal RJJ, Vollan AZ, Wang S, Welkenhuysen M, Ye Z, Dudman JT, Dutta B, Hantman AW, Harris KD, Lee AK, Moser EI, O'Keefe J, Renart A, Svoboda K, Häusser M, Haesler S, Carandini M, Harris TD. Steinmetz NA, et al. Science. 2021 Apr 16;372(6539):eabf4588. doi: 10.1126/science.abf4588. Science. 2021. PMID: 33859006 Free PMC article.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators. Oza AM, et al. Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115797 Free PMC article. Clinical Trial.
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses.
Schandelmaier S, Briel M, Varadhan R, Schmid CH, Devasenapathy N, Hayward RA, Gagnier J, Borenstein M, van der Heijden GJMG, Dahabreh IJ, Sun X, Sauerbrei W, Walsh M, Ioannidis JPA, Thabane L, Guyatt GH. Schandelmaier S, et al. CMAJ. 2020 Aug 10;192(32):E901-E906. doi: 10.1503/cmaj.200077. CMAJ. 2020. PMID: 32778601 Free PMC article.
Accessing populations of motor units.
Kirk EA, Sauerbrei BA. Kirk EA, et al. Elife. 2024 Jan 4;13:e94764. doi: 10.7554/eLife.94764. Elife. 2024. PMID: 38175188 Free PMC article.
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM, Griebsch I, Bottomley A; SISAQOL-IMI Consortium. Pe M, et al. Lancet Oncol. 2023 Jun;24(6):e270-e283. doi: 10.1016/S1470-2045(23)00157-2. Lancet Oncol. 2023. PMID: 37269858 Free article. Review.
519 results